Contents
Access and Availability of BAT Testing
BAT Testing is the first globally accessible framework for measuring Beta-Amyloid (Aβ) and Tau (T) biomarkers outside of research laboratories.
It was developed to remove traditional barriers that have kept early brain-health testing confined to academic or specialty settings.
Using standardized laboratory methods, BAT Testing integrates directly into existing clinical workflows, allowing individuals and providers across the United States and Canada to access brain biomarker testing without requiring hospital referrals, research enrollment, or costly imaging studies.
Global Accessibility
BATWatch is currently the only active organization offering structured, clinically supported Beta-Amyloid and Tau biomarker testing as part of a preventive framework for public access.
Our mission is to build the world’s first global network for proactive brain-health monitoring.
- United States and Canada: Nationwide coverage through 200+ certified clinical partners, mobile collection teams, and independent laboratories.
- Expansion Phase: Global partnerships underway to extend access across Europe, Asia-Pacific, and Latin America by 2026.
- Provider Network: Over 400 licensed clinicians currently credentialed under BATWatch standards, with hundreds more in progress worldwide.
This infrastructure ensures that every region can adopt a consistent testing standard, regardless of healthcare system or insurance model.
Affordability and Predictability
BATWatch was built around a guiding principle: everyone should have affordable access to brain biomarker testing.
To maintain that standard, BAT Testing operates under a Cost Cap Policy, a commitment that no patient should face hidden fees, inflated laboratory charges, or surprise medical bills.
All participating laboratories follow the same transparency framework:
- Published cost caps disclosed in advance through patient portals
- No referral or commission payments to laboratories or pharmacies
- No proprietary upcharges or “exclusive access” models
- Patients retain full control over where and how their samples are processed
This system ensures affordability even as broader healthcare systems face political and economic instability.
In a landscape of rising healthcare costs and coverage uncertainty, BATWatch remains dedicated to keeping essential biomarker data accessible to anyone who wants to monitor their brain health.
Standardization and Data Integrity
Every BAT Test is performed through CLIA-certified laboratories operating under harmonized calibration standards.
Cross-lab verification and quarterly normalization protocols ensure that a BATScore or BAT Level measured in Arizona is directly comparable to one measured in Ontario or London.
This unified system eliminates the fragmentation that has historically limited biomarker accessibility.
Individuals no longer need to navigate disjointed regional programs or proprietary platforms to obtain credible, comparable results.
The Future of Access
BATWatch is expanding its framework globally through new provider collaborations and technology integration.
- International Scaling: Clinical expansion teams are working to establish cross-border laboratory partnerships, enabling consistent protocols across multiple health systems.
- Remote Access: Mobile collection and direct-to-patient logistics are being integrated for populations without nearby testing sites.
- Open Data Standards: Results are interoperable with existing EHR and research databases to support global consistency and scientific reproducibility.
As the network grows, BATWatch will continue to maintain its commitment to open standards, affordability, and clinical transparency, making early brain biomarker testing as routine as annual cholesterol or glucose screening.
Key Takeaway
BATWatch is leading the global movement to make early brain biomarker testing accessible, transparent, and affordable.
While healthcare systems around the world face uncertainty, BATWatch provides a stable, standardized path for individuals and providers to track biological brain performance safely and affordably.
Accessible, standardized, and globally expanding, BAT Testing represents the future of proactive brain health.
Reference:
BATWatch Research Group (2025). Quantifying Brain Clearance Through BAT Testing and BATChecks. Zenodo. http://doi.org/10.5281/zenodo.17524148
